by Jordana Choucair | Jun 3, 2022 | Life Sciences
The White House said Thursday that COVID-19 vaccinations for children under 5 could begin as soon as June 21, if the Food and Drug Administration (FDA) authorizes the shots. White House COVID-19 response coordinator Ashish Jha told reporters that the Biden...
by Jordana Choucair | Jun 3, 2022 | Life Sciences
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) said it will investigate the FDA’s actions leading up to the recall of baby formula made at Abbott’s Michigan facility. In September 2021 the FDA conducted a “routine surveillance...
by Jordana Choucair | Jun 2, 2022 | Life Sciences
Pfizer announced that the Food and Drug Administration (FDA) accepted its application for a three-dose COVID-19 vaccine in children aged 6 months to under 5 years old. In February, the FDA asked Pfizer-BioNTech to submit a request for emergency use authorization (EUA)...
by Jordana Choucair | Jun 2, 2022 | Life Sciences
USC’s Schaeffer Center for Health Policy and Economics released a report examining how pharmacy benefit managers’ (PBMs) tactics such as spread pricing and copay clawbacks are driving up consumers’ costs for generic drugs. For example, Medicare Part D standalone drug...
by Jordana Choucair | May 31, 2022 | Life Sciences
Next week a key Food and Drug Administration (FDA) advisory committee will examine Novavax’s application for an emergency use authorization for its COVID-19 vaccine for adults 18 and older. Novavax originally planned to ask FDA for authorization by May 2021 but...
by Jordana Choucair | May 31, 2022 | Life Sciences
British drugmaker GSK PLC will buy vaccine manufacturer Affinivax Inc. for up to $3.3 billion, giving it access to promising experimental vaccine technology that targets two dozen common diseases. A GSK executive said Affinivax’s technology could broaden...
Recent Comments